Table 1.
Clinical characteristics of GBM samples from adult and pediatric patients analyzed using the Illumina 100K SNP array
| GBM | Gender | Age at Diagnosis (Years) | Tumor Location |
|---|---|---|---|
| Pediatric | |||
| P1 | M | 9 | Infratentorial |
| P2 | F | 6 | Supratentorial (frontal) |
| P3 | F | 10 | Supratentorial (parietal) |
| P4 | F | 14 | Supratentorial (parietal) |
| P5 | M | 14 | Supratentorial (frontal) |
| P6 | M | 14 | Supratentorial (temporal) |
| P7 | F | 9 | Supratentorial (multilobar) |
| P8 | M | 3 | Supratentorial (temporal) |
| P9 | F | 11 | Supratentorial (temporal) |
| P10 | F | 13 | Supratentorial (frontal) |
| P11 | M | 7 | Supratentorial (thalamic) |
| P12 | F | 16 | Infratentorial |
| P13 | M | 16 | Infratentorial |
| P14 | M | 13 | Infratentorial |
| P15 | M | 15 | Infratentorial |
| P16 | F | 12 | Supratentorial (parietal) |
| P17 | F | 10 | Infratentorial |
| P18 | M | 13 | Mixed |
| Adult | |||
| Secondary | |||
| A1 | M | 52 | Supratentorial (multilobar) |
| A2 | F | 49 | Supratentorial (frontal) |
| A3 | M | 67 | Supratentorial (thalamic) |
| Primary | |||
| A4 | F | 30 | Supratentorial (parietal) |
| A5 | M | 70 | Supratentorial (temporal) |
| A6 | F | 82 | Supratentorial (frontal) |